X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs GSK PHARMA - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD GSK PHARMA STRIDES SHASUN LTD/
GSK PHARMA
 
P/E (TTM) x 14.3 59.5 24.0% View Chart
P/BV x 1.9 11.7 16.6% View Chart
Dividend Yield % 0.5 2.1 25.5%  

Financials

 STRIDES SHASUN LTD   GSK PHARMA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-16
GSK PHARMA
Mar-16
STRIDES SHASUN LTD/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,4133,850 36.7%   
Low Rs8482,966 28.6%   
Sales per share (Unadj.) Rs353.3332.3 106.3%  
Earnings per share (Unadj.) Rs23.444.3 52.8%  
Cash flow per share (Unadj.) Rs41.047.2 86.8%  
Dividends per share (Unadj.) Rs5.0050.00 10.0%  
Dividend yield (eoy) %0.41.5 30.2%  
Book value per share (Unadj.) Rs320.4202.7 158.1%  
Shares outstanding (eoy) m89.3584.70 105.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x3.210.3 31.2%   
Avg P/E ratio x48.376.9 62.8%  
P/CF ratio (eoy) x27.672.2 38.2%  
Price / Book Value ratio x3.516.8 21.0%  
Dividend payout %21.4112.9 18.9%   
Avg Mkt Cap Rs m100,988288,643 35.0%   
No. of employees `0004.74.6 101.7%   
Total wages/salary Rs m4,9884,434 112.5%   
Avg. sales/employee Rs Th6,730.06,104.5 110.2%   
Avg. wages/employee Rs Th1,063.6961.6 110.6%   
Avg. net profit/employee Rs Th445.5813.7 54.8%   
INCOME DATA
Net Sales Rs m31,56428,148 112.1%  
Other income Rs m1,2121,218 99.5%   
Total revenues Rs m32,77629,366 111.6%   
Gross profit Rs m5,2134,774 109.2%  
Depreciation Rs m1,573248 634.2%   
Interest Rs m1,8030-   
Profit before tax Rs m3,0495,744 53.1%   
Minority Interest Rs m1270-   
Prior Period Items Rs m-270-   
Extraordinary Inc (Exp) Rs m-37126 -1,426.7%   
Tax Rs m6892,018 34.1%   
Profit after tax Rs m2,0893,752 55.7%  
Gross profit margin %16.517.0 97.4%  
Effective tax rate %22.635.1 64.3%   
Net profit margin %6.613.3 49.7%  
BALANCE SHEET DATA
Current assets Rs m35,94921,462 167.5%   
Current liabilities Rs m19,40210,536 184.1%   
Net working cap to sales %52.438.8 135.1%  
Current ratio x1.92.0 91.0%  
Inventory Days Days7168 104.8%  
Debtors Days Days12716 772.4%  
Net fixed assets Rs m34,4784,717 730.9%   
Share capital Rs m894847 105.5%   
"Free" reserves Rs m22,60116,308 138.6%   
Net worth Rs m28,63217,171 166.7%   
Long term debt Rs m27,45516 171,592.5%   
Total assets Rs m76,59130,620 250.1%  
Interest coverage x2.7NM-  
Debt to equity ratio x1.00 102,909.3%  
Sales to assets ratio x0.40.9 44.8%   
Return on assets %5.112.3 41.5%  
Return on equity %7.321.9 33.4%  
Return on capital %8.233.6 24.3%  
Exports to sales %48.10 338,708.1%   
Imports to sales %14.515.1 96.1%   
Exports (fob) Rs m15,1924 379,807.5%   
Imports (cif) Rs m4,5654,237 107.7%   
Fx inflow Rs m16,612519 3,200.8%   
Fx outflow Rs m5,2928,320 63.6%   
Net fx Rs m11,320-7,801 -145.1%   
CASH FLOW
From Operations Rs m7171,386 51.7%  
From Investments Rs m-22,2845,010 -444.8%  
From Financial Activity Rs m29,488-6,383 -461.9%  
Net Cashflow Rs m8,07312 68,415.0%  

Share Holding

Indian Promoters % 27.7 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 37.8 10.2 370.6%  
FIIs % 8.6 23.8 36.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 15.4 168.2%  
Shareholders   56,241 102,036 55.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   PLETHICO PHARMA  DIVIS LABORATORIES  UNICHEM LAB  ALKEM LABORATORIES  ELDER PHARMA  

Compare STRIDES SHASUN LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Realty Sector Up 2.7%(11:30 am)

After opening the day higher, stock markets in India have continued their momentum. Sectoral indices are trading on a positive note with stocks in the realty sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Aug 23, 2017 12:32 PM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS